Literature DB >> 18772552

Establishment of a LacZ marker rescue assay to detect infectious RD114 virus.

Shoichi Sakaguchi1, Masaya Okada, Takayuki Shojima, Kenji Baba, Takayuki Miyazawa.   

Abstract

Cats have an infectious endogenous retrovirus, named RD114 virus, and there is a possibility that RD114 virus has contaminated live attenuated vaccines, for which feline cells are used as a substrate. To monitor infectious RD114 virus in vaccines for cats, we developed a LacZ marker rescue assay to detect infectious RD114 virus. Among four human cell lines examined, TE671 cells (human rhabdomyosarcoma) were most susceptible to RD114 virus and supported RD114 replication efficiently. Infection was enhanced approximately 5 times by the addition of polybrene at concentrations of 2 to 8 microg/ml in the medium during viral adsorption. A 4-hr viral adsorption period was sufficient to obtain the maximum titer. By inoculating samples into TE671 cells transduced with the lacZ marker gene, the limiting diluted sample (i.e., less than 10 infectious units) was detected at 12 days post-inoculation by the LacZ marker rescue assay. Based on the results obtained in this study, we propose a standard protocol of the LacZ marker rescue assay to detect infectious RD114 virus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772552     DOI: 10.1292/jvms.70.785

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  16 in total

1.  Sequence comparison of three infectious molecular clones of RD-114 virus.

Authors:  Sayumi Shimode; Rokusuke Yoshikawa; Shigeki Hoshino; Yuki Nakaya; Shoichi Sakaguchi; Takeshi Kobayashi; Takayuki Miyazawa
Journal:  Virus Genes       Date:  2012-05-26       Impact factor: 2.332

2.  Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells.

Authors:  Rokusuke Yoshikawa; Eiji Sato; Tatsuhiko Igarashi; Takayuki Miyazawa
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

3.  Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets.

Authors:  Takayuki Miyazawa; Rokusuke Yoshikawa; Matthew Golder; Masaya Okada; Hazel Stewart; Massimo Palmarini
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

4.  A unique, thermostable dimer linkage structure of RD114 retroviral RNA.

Authors:  Sergei Kharytonchyk; Finn Skou Pedersen
Journal:  RNA       Date:  2010-01-14       Impact factor: 4.942

5.  Simian retrovirus 4 induces lethal acute thrombocytopenia in Japanese macaques.

Authors:  Rokusuke Yoshikawa; Munehiro Okamoto; Shoichi Sakaguchi; So Nakagawa; Tomoyuki Miura; Hirohisa Hirai; Takayuki Miyazawa
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

6.  Construction and characterization of an infectious molecular clone of Koala retrovirus.

Authors:  Takayuki Shojima; Shigeki Hoshino; Masumi Abe; Jiro Yasuda; Hiroko Shogen; Takeshi Kobayashi; Takayuki Miyazawa
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

7.  Experimental infection of dogs with a feline endogenous retrovirus RD-114.

Authors:  Rie Narushima; Noriyuki Horiuchi; Tatsufumi Usui; Takashi Ogawa; Toshio Takahashi; Tomoaki Shimazaki
Journal:  Acta Vet Scand       Date:  2011-01-27       Impact factor: 1.695

8.  Cloning and characterization of the antiviral activity of feline Tetherin/BST-2.

Authors:  Aiko Fukuma; Masumi Abe; Yuko Morikawa; Takayuki Miyazawa; Jiro Yasuda
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

9.  Evaluation of membrane filtration system using The "Pore Diffusion" for eliminating viruses.

Authors:  Akira Hashimoto-Gotoh; Takahiro Matsuki; Takayuki Miyazawa
Journal:  J Vet Med Sci       Date:  2015-02-26       Impact factor: 1.267

10.  A new approach to establish a cell line with reduced risk of endogenous retroviruses.

Authors:  Aiko Fukuma; Rokusuke Yoshikawa; Takayuki Miyazawa; Jiro Yasuda
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.